Literature DB >> 2210623

Hormone epidermal growth factor interactions in development.

D A Fisher1.   

Abstract

Epidermal growth factor (EGF) is the most important member of a family of growth factors which exert their effects via a single 170,000 Mr plasma membrane receptor. Other members include transforming growth factor-alpha (TGF-alpha), amphiregulin and several viral growth factors. The receptor is widely distributed in fetal and postnatal tissues. The predominant family member in the fetus appears to be TGF-alpha. EGF production in tissues matures in the perinatal period. Activation of the receptor in the fetal and neonatal periods in rodents evokes important growth and development actions. Tissue EGF and EGF receptor concentrations are modulated by thyroid hormones, estrogen, testosterone and growth hormone, suggesting that selected growth and developmental actions of thyroid and steroid hormones may be mediated by EGF.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210623     DOI: 10.1159/000181487

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Immobilization stress induces c-Fos accumulation in liver.

Authors:  G Fernández; M P Mena; A Arnau; O Sánchez; M Soley; I Ramírez
Journal:  Cell Stress Chaperones       Date:  2000-10       Impact factor: 3.667

2.  Androgen regulation of epidermal growth factor receptor binding activity during fetal rabbit lung development.

Authors:  J M Klein; H C Nielsen
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

3.  Evaluation of EGFR inhibitor-mediated acneiform skin toxicity within the double-blind randomized EVITA trial: A thorough gender-specific analysis using the WoMo score.

Authors:  Maria R Gaiser; Sylvie Lorenzen; Kirsten Merx; Jörg Trojan; Janja Ocvirk; Thomas J Ettrich; Salah-Eddin Al-Batran; Holger Schulz; Nils Homann; Hans-Peter Feustel; Michael Schatz; Melanie Kripp; Nadine Schulte; Steffen Heeger; Soetkin Vlassak; Winfried Koch; Ralf-Dieter Hofheinz
Journal:  Cancer Med       Date:  2019-06-14       Impact factor: 4.452

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.